Xerox Corp (XRX)
Official siteINDUSTRIALS • INFORMATION TECHNOLOGY SERVICES • NASDAQ
Market Cap: $125.47M
Last updated: Nov 17, 2026 at 11:06 AM ET
Xerox Corp (XRX) Stock Forecast
Analysts expect Xerox (XRX) to earn -$0.15 per share in the fiscal year ending Dec 31, 2026, on revenue of $7.59B. Of 4 analysts, 1 rates the stock Buy or Strong Buy, 1 Hold and 2 Sell or Strong Sell, for a consensus of Sell. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 2 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 4 ratings average 3.50, inside the Sell band from 3.5 up to 4.5. Sell and Strong Sell make up 50% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 1 | 25.0% |
| Hold | 1 | 25.0% |
| Sell | 1 | 25.0% |
| Strong Sell | 1 | 25.0% |
- Consensus
- Sell
- Total analysts
- 4
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a larger loss and revenue estimates fall 2.0%.
- Fiscal year ending Dec 31, 2026
- -$0.15
- EPS consensus, revenue $7.59B
- Fiscal year ending Dec 31, 2027
- -$0.29
- EPS consensus, revenue $7.44B
- Next report
- Jan 27, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.15 | -$0.17 to -$0.13 | 2 | $7.59B | $7.57B to $7.60B | 4 |
| Dec 31, 2027 | -$0.29 | -$0.33 to -$0.25 | 2 | $7.44B | $7.43B to $7.45B | 4 |
Quarterly Estimates
The EPS consensus falls from $0.13 for the quarter ending Dec 31, 2026 to -$0.14 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.13 | -$0.19 to $0.33 | 5 | $1.97B | $1.89B to $2.06B | 5 |
| Mar 31, 2027 | -$0.14 | -$0.21 to -$0.07 | 2 | $1.81B | $1.81B to $1.81B | 2 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 0 upward and 4 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 2 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
| Quarter ending Mar 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has turned from a profit of $0.14 to a loss.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.15 | $0.14 | $0.14 | $0.14 | $0.14 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.29 | $0.30 | $0.30 | $0.30 | $0.30 | N/A |
| Quarter ending Mar 31, 2027 | -$0.14 | $0.04 | $0.04 | $0.04 | $0.04 | N/A |
Frequently Asked Questions About XRX
What is the XRX stock forecast?
Consensus analyst estimates put Xerox's EPS at -$0.15 for the fiscal year ending Dec 31, 2026, on revenue of $7.59B. The consensus rating from 4 analysts is Sell.
How do analysts rate XRX stock?
Of 4 analysts covering Xerox, 0 rate it Strong Buy, 1 Buy, 1 Hold, 1 Sell and 1 Strong Sell, for a consensus of Sell.
What EPS do analysts expect from XRX next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.15, with estimates from -$0.17 to -$0.13 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.29, with estimates from -$0.33 to -$0.25 from 2 analysts.
What revenue do analysts expect from Xerox next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $7.59B, with estimates from $7.57B to $7.60B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $7.44B, with estimates from $7.43B to $7.45B.
How many analysts cover XRX?
4 analysts rate Xerox stock, and 2 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
XRX pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts